SCHEMBL2054319

SCHEMBL2054319

COc1cc(C(=O)N(C)[C@H](CCNC(=O)c2cccn2C)Cc2ccccc2)cc(C)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.64
HCRTR2 O43614 2/20 0.64
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
OPRM1 P35372 1/20 0.39
OPRK1 P41145 1/20 0.39
ALDH1A1 P00352 1/20 0.37
HRH3 Q9Y5N1 2/20 0.37
SMYD2 Q9NRG4 1/20 0.37
PADI4 Q9UM07 3/20 0.35
HTR1A P08908 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016237 1.00 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9AOPRM1
SCHEMBL2014960 0.96 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL6919067 0.96 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2011910 0.92 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9AOPRM1
SCHEMBL6919382 0.92 HCRTR1 (0.72) HCRTR1HCRTR2NPC1RAB9AOPRM1
SCHEMBL2010949 0.92 HCRTR1 (0.72) HCRTR1HCRTR2NPC1RAB9AOPRM1
SCHEMBL2012235 0.91 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL2016685 0.90 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AOPRM1
SCHEMBL2017217 0.88 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2010845 0.88 HCRTR1 (0.63) HCRTR1HCRTR2NPC1RAB9AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed